With the analysis among 884 patents, we discovered top 217 key players by total patent application. Immatics Biotechnologies GmbH, CRISPR Therapeutics AG, Ganymed Pharmaceuticals AG are dominant in this area. They take 24.43% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 116
Massachusetts, United States
Patent: 64
Ganymed Pharmaceuticals AG
Rheinland-Pfalz, Germany
Patent: 36
CHESHIRE, United Kingdom
Patent: 29
International Institute of Cancer Immunology, Inc.
Ortho Pharmaceutical Corp.
New Jersey, United States
Patent: 24
Washington, United States
Patent: 21
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 15
Utrecht, Netherlands
Patent: 14
With the analysis among 40 patents, we discovered top 11 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, NeoCura Bio-Medical Technology Co., Ltd., 3T Biosciences, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
NeoCura Bio-Medical Technology Co., Ltd.
Guangdong Sheng, China
Patent: 5
California, United States
Patent: 5
Utrecht, Netherlands
Patent: 5
California, United States
Patent: 4
Illinois, United States
Patent: 2
ZURICH, Switzerland
Patent: 1
Shenzhen Neoimmune Co Ltd.
Guangdong Sheng, China
Patent: 1
Beijing Xiangxin Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
With the analysis among related 412 patents applied in the last 5 years. We discover 131 most active companies in this area. The fast-growing CRISPR Therapeutics AG, United States of America, Sana Biotechnology, Inc. take 29.13% of patent filing during this period.
Massachusetts, United States
Patent: 64
Washington, United States
Patent: 21
Department of Health & Human Services
China Medical University Hospital
President & Fellows of Harvard College
Massachusetts, United States
Patent: 14
The Board of Regents of The University of Texas System
Texas, United States
Patent: 13
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 9
Texas, United States
Patent: 8
With the analysis among related 412 patents in last 5 years, we discover 92 new entrants. CRISPR Therapeutics AG, Sana Biotechnology, Inc., Department of Health & Human Services are the most active new entrants in this area.
Massachusetts, United States
Patent: 64
Washington, United States
Patent: 21
Department of Health & Human Services
China Medical University Hospital
Texas, United States
Patent: 8
Cedars-Sinai Medical Center
California, United States
Patent: 8
Ohio, United States
Patent: 6
California, United States
Patent: 5
With the analysis among 314 patents, we discovered top 44 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, University of Birmingham, The University of North Carolina at Chapel Hill are dominant in this area. They take 33.12% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 24
Birmingham, United Kingdom
Patent: 12
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 11
The Johns Hopkins University
North Carolina State University
North Carolina, United States
Patent: 8
Minnesota, United States
Patent: 7
Shanghai Shi, China
Patent: 6
Institute For Basic Science
Institut Gustave Roussy EURL